CompletedPhase 4NCT06346834
Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers
Studying Poliomyelitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sinovac Biotech Co., Ltd
- Principal Investigator
- Lei WangHubei Provincial Center for Disease Control and Prevention
- Intervention
- sIPV(biological)
- Enrollment
- 200 enrolled
- Eligibility
- All sexes
- Timeline
- 2024 – 2024
Study locations (1)
- Disease Control and Prevention Center, Xiaonan District, Xiaogan City, Xiaogan, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06346834 on ClinicalTrials.govOther trials for Poliomyelitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07457060Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus VaccineSinovac Biotech Co., Ltd
- RECRUITINGPHASE2NCT06895486Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines EvaluationPATH
- RECRUITINGPHASE4NCT07354269Phase IV Clinical Study of sIPV Administration in Adolescent and Adult PopulationsSinovac Biotech Co., Ltd
- RECRUITINGPHASE1, PHASE2NCT06577298A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and ToddlersCanSino Biologics Inc.
- RECRUITINGPHASE1, PHASE2NCT06137664Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis VaccinesPATH
- ACTIVE NOT RECRUITINGNANCT06218368A Tool Kit to Improve Vaccine Confidence in the PhilippinesUniversity of Toronto
- RECRUITINGPHASE2NCT05654467Study of a Novel Type 3 Oral Poliomyelitis Vaccine in PanamaPATH
- RECRUITINGPHASE2NCT05644184Study of a Novel Type 1 Oral Poliomyelitis Vaccine in BangladeshPATH